Qualcomm Inc. (0QZ3)
London Exchange · UK · prices in USD · close of 21 Oct 2026
Key indicators
| Last close | USD 173.50 |
|---|---|
| 52-week range | 121.97 – 259.95 |
| Return, 1 month / 3 months | −11.4% / +2.7% |
| Return, 1 year / 3 years | +8.0% / +66.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 44 |
| Volatility (1 year) | 55.2% |
| Worst drawdown (1 year) | -41.2% |
| Average daily value traded | 5.29M USD |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Qualcomm is a technology company based in San Diego that designs chips and related hardware for mobile devices and other connected products. Its Snapdragon line of processors and modems powers smartphones and tablets made by many device manufacturers. The company also licenses its portfolio of wireless technology patents to handset makers and other equipment producers, earning royalties on cellular standards. Its customers include phone makers, network operators and automotive and electronics firms around the world.
Qualcomm Inc. trades under the code 0QZ3 on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Qualcomm Inc. (0QZ3) trades on the London Exchange in UK. It last closed at USD 173.50 on 21 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 1,836 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.0% and over the last three months it rose 2.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 2.1% | ||
| From 52-week high | -31.0% | ||
| Momentum | 73 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 2.7% | ||
| 6-month return | 28.0% | ||
| 12-month return, skipping the last month | 21.8% | ||
| Stability (higher is calmer) | 26 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 55.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.2% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 5.29M USD | ||
| Zero-volume days | 1.7% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 6 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +0.8% |
|---|---|
| 1 month | −11.4% |
| 3 months | +2.7% |
| 6 months | +28.0% |
| 1 year | +8.0% |
| 3 years | +66.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 175.85 / 169.94 |
|---|---|
| Golden / death cross (60 days) | Golden, 19 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.04 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Mar 2026 | USD 0.8900 |
| 3 Dec 2025 | USD 0.8900 |
| 3 Sep 2025 | USD 0.8900 |
| 4 Jun 2025 | USD 0.8900 |
| 5 Mar 2025 | USD 0.8500 |
| 5 Dec 2024 | USD 0.8500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.